The New Republic on MSN9hOpinion
What to Expect From Trump’s Next Term: More E. Coli and Fewer Vaccines
Virus monitoring, the budgets to investigate E. coli outbreaks, and much, much more could be on the chopping block.
Hosted on MSN3h
Sanford looks to restrict needle exchange with emergency ordinance
According to the U.S. CDC, new users enrolling in syringe service ... to worse health outcomes for people who inject drugs. Not only can reusing or sharing needles spread blood-borne diseases like HIV ...
BioPharma Dive3h
FDA approves new CAR-T competitor to Gilead’s Tecartus
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
US FDA lifts clinical hold on Novavax's combo COVID-flu shot
The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.
FiercePharma4h
Humira, Cosentyx gaining favor as treatments for hidradenitis suppurativa, but more support for biologics needed: Spherix
Doctors have been fairly quick to jump on the biologics train: According to Spherix, 96% of dermatologists reported using ...
US minority veterans face unequal access to Ozempic and Wegovy, study finds
U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...
Unicycive: FDA to Review Lead Drug Candidate for Hyperphosphatemia
Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...
New York Sun20h
The New York Sun
One professor who announced that class would end early, lamented that ‘processing the results of a national election can be heavy’ and ‘having space to breathe and go a bit slower is vital.’ It isn’t ...